sovereign digital currency, Featured

The Baltic dry bulk freight index fell 0.38% to 1051 points.Market News: US Secretary of State Blinken met with Iraqi Prime Minister in Baghdad to discuss the Syrian issue.Market news: South Korean court issued an arrest warrant to Seoul police chief.

Musk received an ultimatum from the SEC or faced multiple accusations, and the long-term confrontation between the US SEC and Musk escalated again. On December 12th, local time, Alex spiro, a lawyer of Musk, wrote to Gary Gensler, the outgoing chairman of the SEC, accusing the agency of launching an "ulterior motive action" against Musk, and revealed that the SEC had restarted the investigation of Neuralink, a brain-computer interface company owned by Musk. According to the contents of the letter, the SEC asked Musk to accept the settlement agreement within 48 hours and pay the fine, otherwise he would face "multiple accusations". These allegations are related to Musk's stock investment behavior before the acquisition of Twitter (now "X") in 2022, involving trading time and the legality of information disclosure. It was mentioned in the letter that the accusation originated from an investigation that lasted for several years, and the SEC recently issued a subpoena to Musk's lawyer, asking him to provide testimony. Alex spiro said that he had explicitly refused to cooperate and accused the agency of "political motives". Musk also posted a letter from his lawyer to Gary Gensler on social media, with the text "Gary, how could you do this to me" and a crying emoji. Alex spiro also asked in his letter who was directing the SEC's actions. Alex spiro emphasized that the SEC's "harassment" of Musk and its affiliates for six years has deviated from the original intention of seeking the truth and become an improper pressure. At present, the SEC has not commented on this. In addition, the letter said that the SEC also restarted the investigation of Neuralink, a brain-computer interface company owned by Musk. This autumn, the animal protection organization "Committee of Responsible Medical Doctors" and four US congressmen asked the SEC to investigate Neuralink, accusing it of securities fraud through misleading propaganda. (Securities Times)Zhuhai Guanyu: It has been notified by domestic car companies. Zhuhai Guanyu announced that the company has recently been notified by a domestic car company to select the company as its designated supplier to develop and supply low-voltage lithium batteries for 12V cars.Sources: Russia has suspended grain exports to Syria. Russian and Syrian sources said on Friday that Russia's wheat supply to Syria has been suspended due to the uncertainty of the new Syrian government and the delay in payment.

Hikvision: The controlling shareholder has obtained a commitment letter for a special loan of 120 million yuan to increase its holdings. Hikvision announced that the company recently received a notice from the controlling shareholder, CLP Hikvision, that CLP Hikvision has obtained a commitment letter for a special loan to increase its holdings issued by China Industrial and Commercial Bank of China. Hangzhou Branch of Industrial and Commercial Bank of China will provide a loan fund of no more than 120 million yuan for CLP Hikvision Group to increase its shareholding in Hikvision by centralized bidding, and the loan period will not exceed 3 years.Guoyuan Securities: A special dividend plan was drawn up and announced by Guoyuan Securities. On December 13, 2024, the company held the 20th meeting of the 10th Board of Directors and the 11th meeting of the 10th Board of Supervisors, at which the Proposal on Special Dividend Plan was reviewed and approved. As of September 30, 2024, the accumulated undistributed profit of the company was 7.743 billion yuan, and the accumulated distributable profit of the parent company was 5.262 billion yuan. In order to enhance the investor's sense of gain and improve the investor's return level, the company has drawn up a special dividend plan: based on the existing total share capital of 4.364 billion shares, a cash dividend of 0.60 yuan will be distributed to all shareholders for every 10 shares, and a total cash dividend of 262 million yuan will be distributed. No bonus shares will be distributed, and capital will not be increased from the provident fund.Kang Enbei: Amikacin Sulfate Injection is planned to win the bid for the tenth batch of national centralized drug purchase. On December 12th, Kang Enbei and its wholly-owned subsidiary Jinhua Kang Enbei participated in the bidding for the tenth batch of national centralized drug purchase organized by the National Joint Procurement Office for Centralized Drug Purchase and Use. After the bid opening and bid evaluation by the Joint Procurement Office, the company's product Amikacin Sulfate Injection plans to win the bid for this centralized procurement, and the supply provinces have been selected according to the market potential of each province. The successful results will be officially released after being publicized by the Joint Procurement Office. Amikacin sulfate injection is suitable for the treatment of serious infections caused by Pseudomonas aeruginosa, other Pseudomonas, Escherichia coli and other sensitive gram-negative bacilli and Staphylococcus (methicillin-sensitive strains). Compared with the original price, the price of the product to be selected this time has dropped to a certain extent.